Monday, January 19, 2026 2:15:09 AM
Indeed, it presented as a brain abscess in my right temporal lobe, and was treated as such with large doses of IV antibiotics administered via a picc line directly onto my chest plate.
A burr hole procedure then drained the puss out.
With a craniotomy undertaken, the now calcified abscess particles were removed .
Pathology then and some years later also, on the physical archived slides, confirmed GBM4 once again.
Fortunately I had a very rare, if not unique, immune response to the emergent brain cancer.
I was lucky, of course, but what it gave me, was a unique insight into the dehumanising nature of the Cancer Treating Industrial Complex, and how each patient's outcome is treated as no more than a point on a statistical graph.
So as you all, with sweaty palms, dream of a return on your investment, remember that real people died in this trial, hoping that this faux vaccine would help them.
If this DCVAX-L trial result had merit, I would support it, but I don't, as it was clearly no more than grift & a lie to make people rich, and be damned with the consequences & heartbreak.
At this stage, it is virtually impossible for the Regulator to approve this 'treatment', as they are aware of every single piece of public record that questions the veracity of the -L results, trial format & NWBO's efficacy over 20+ years of operation.
Upto and including their financial volatility and supply chain issues.
A burr hole procedure then drained the puss out.
With a craniotomy undertaken, the now calcified abscess particles were removed .
Pathology then and some years later also, on the physical archived slides, confirmed GBM4 once again.
Fortunately I had a very rare, if not unique, immune response to the emergent brain cancer.
I was lucky, of course, but what it gave me, was a unique insight into the dehumanising nature of the Cancer Treating Industrial Complex, and how each patient's outcome is treated as no more than a point on a statistical graph.
So as you all, with sweaty palms, dream of a return on your investment, remember that real people died in this trial, hoping that this faux vaccine would help them.
If this DCVAX-L trial result had merit, I would support it, but I don't, as it was clearly no more than grift & a lie to make people rich, and be damned with the consequences & heartbreak.
At this stage, it is virtually impossible for the Regulator to approve this 'treatment', as they are aware of every single piece of public record that questions the veracity of the -L results, trial format & NWBO's efficacy over 20+ years of operation.
Upto and including their financial volatility and supply chain issues.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
